Publication

The Effect of Metabolic Syndrome on the Occurrence of Restenosis After Carotid Endarterectomy

de Vries, B. M. W., Timmerman, N., van Laarhoven, C. J. H. C. M., Visser, L., Pol, R. A., El Moumni, M., Pasterkamp, G., de Borst, G. J. & Zeebregts, C. J., Dec-2019, In : European Journal of Vascular and Endovascular Surgery. 58, 6, p. 805-812 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Copy link to clipboard

Documents

  • The Effect of Metabolic Syndrome on the Occurrence of Restenosis After Carotid Endarterectomy

    Final author's version, 211 KB, PDF document

    Embargo ends: 29/11/2020

    Request copy

  • The Effect of Metabolic Syndrome on the Occurrence of Restenosis After Carotid Endarterectomy

    Final publisher's version, 445 KB, PDF document

    Request copy

DOI

Objectives: The metabolic syndrome (MetS) is a cluster of risk factors for cardiovascular disease. The effect of MetS on clinical outcome in patients with cerebrovascular disease remains largely unknown because conflicting results have been published. This study aimed to determine the influence of MetS on the occurrence of restenosis after carotid endarterectomy (CEA).

Methods: All patients who underwent CEA between June 2003 and December 2014 in two tertiary academic referral centres in The Netherlands were included. MetS was defined if three or more of the following criteria were present: hypertension, obesity, high fasting serum blood glucose, high serum triglycerides, or low serum high density lipoprotein cholesterol. The primary outcome measure was the occurrence of ipsilateral restenosis after index surgery. The secondary outcome measure was (all cause) mortality during follow up. For the primary analysis, missing data were multiply imputed using multivariable imputation by chained equations. A Cox proportional hazards model was used to perform an adjusted analysis on the multiply imputed data sets.

Results: A total of 1668 CEA procedures (in 1577 patients) were performed. The presence or absence of MetS could not be determined in 263 patients because of missing data. There was no significant difference in freedom from restenosis in the MetS group vs. the no-MetS group (hazard ratio [HR], 1.10; 95% confidence interval [CI] 0.98-1.23; p = .10) or in all cause mortality (HR 1.20; 95% CI 0.94-1.54; p = .14).

Conclusion: This study shows that MetS does not predict restenosis after CEA. Also, the presence of MetS did not influence patient survival negatively.

Original languageEnglish
Pages (from-to)805-812
Number of pages8
JournalEuropean Journal of Vascular and Endovascular Surgery
Volume58
Issue number6
Publication statusPublished - Dec-2019

    Keywords

  • Metabolic syndrome, Carotid endarterectomy, Restenosis, Survival, Surveillance, PLAQUE, ATHEROSCLEROSIS, ASSOCIATION, CHOLESTEROL, OUTCOMES, STENOSIS, RISK

ID: 109501210